文献速递慢阻肺

D-PPAC与C-PPAC仪器的信效度及反应性验证

Validity and responsiveness of the Daily- and Clinical visit-PROactive Physical Activity in COPD (D-PPAC and C-PPAC) instruments.
PubMed 文献 · Thorax · 2021-01-21

本研究基于七项随机对照试验数据,在1324例不同严重程度和国家的稳定期慢阻肺患者中评估D-PPAC和C-PPAC的身体活动测量工具。结果显示两工具内部一致性高、结构效度好,对药物、肺康复及行为干预均敏感,并确定最小重要差异值:活动量及难度评分6分,总分4分。

要点

  • D-PPAC和C-PPAC在多样慢阻肺人群中信效度良好。
  • 难度评分对药物和肺康复敏感,活动量评分对行为干预敏感。
  • 最小重要差异:活动量/难度6分,总分4分。

核心结论

  • D-PPAC和C-PPAC在多样慢阻肺人群中可靠、有效,且对药物和非药物干预及临床相关变量变化有反应性。

研究设计与样本

  • 基于七项随机对照试验数据,纳入1324例稳定期慢阻肺患者,平均年龄66岁(SD 8),FEV1占预计值55%(SD 17)。
  • 评估内部一致性、结构效度(按性别、年龄、严重程度、国家、语言分层)及对干预的反应性、变化检测能力和MID。

主要发现

  • 评分覆盖0至100几乎全范围,分层后内部一致性强,并与呼吸困难、健康相关生活质量和运动能力按先验假设相关。
  • 难度评分在药物治疗和肺康复后改善,活动量评分在行为身体活动干预后改善。
  • 所有评分对自我报告身体活动体验的变化(恶化和改善)及随访期间慢阻肺急性加重发生均有反应性。

关键数值与推荐

  • MID估计为:活动量评分6分,难度评分6分,总分4分。

临床怎么用

  • 可用于评估慢阻肺患者身体活动体验,并解读药物、肺康复或行为干预后的变化。
  • 变化达到活动量或难度6分、总分4分可视为具有临床意义的最小重要差异。

局限性

  • 数据来源于随机对照试验,可能限制外推至常规临床实践。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Daily-PROactive and Clinical visit-PROactive Physical Activity (D-PPAC and C-PPAC) instruments in chronic obstructive pulmonary disease (COPD) combines questionnaire with activity monitor data to measure patients' experience of physical activity. Their amount, difficulty and total scores range from 0 (worst) to 100 (best) but require further psychometric evaluation. OBJECTIVE: To test reliability, validity and responsiveness, and to define minimal important difference (MID), of the D-PPAC and C-PPAC instruments, in a large population of patients with stable COPD from diverse severities, settings and countries. METHODS: We used data from seven randomised controlled trials to evaluate D-PPAC and C-PPAC internal consistency and construct validity by sex, age groups, COPD severity, country and language as well as responsiveness to interventions, ability to detect change and MID. RESULTS: We included 1324 patients (mean (SD) age 66 (8) years, forced expiratory volume in 1 s 55 (17)% predicted). Scores covered almost the full range from 0 to 100, showed strong internal consistency after stratification and correlated as a priori hypothesised with dyspnoea, health-related quality of life and exercise capacity. Difficulty scores improved after pharmacological treatment and pulmonary rehabilitation, while amount scores improved after behavioural physical activity interventions. All scores were responsive to changes in self-reported physical activity experience (both worsening and improvement) and to the occurrence of COPD exacerbations during follow-up. The MID was estimated to 6 for amount and difficulty scores and 4 for total score. CONCLUSIONS: The D-PPAC and C-PPAC instruments are reliable and valid across diverse COPD populations and responsive to pharmacological and non-pharmacological interventions and changes in clinically relevant variables.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Garcia-Aymerich J, Puhan MA, Corriol-Rohou S, et al. Validity and responsiveness of the Daily- and Clinical visit-PROactive Physical Activity in COPD (D-PPAC and C-PPAC) instruments. Thorax. 2021. PMID: 33479044. doi:10.1136/thoraxjnl-2020-214554

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。